Axogen Shares Fall 13% on Lukewarm 2024 Outlook [MarketWatch]
Axogen, Inc. (AXGN)
Last axogen, inc. earnings: 2/24 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.axogeninc.com
Company Research
Source: MarketWatch
The stock fell 13% to $9.17 on Tuesday. Shares remain up 34% year to date. Advertisement The Florida-based company, which makes surgical solutions for peripheral nerve injuries, guided for full-year revenue between $177 million and $181 million, up between 11% and 14% from $159 million in 2023. Analysts polled by FactSet expect $178.9 million. "We wanted to give guidance that we feel fully confident with," Chief Financial Officer Nir Naor said. Axogen issued lukewarm guidance as it reported fourth-quarter earnings that were above analysts' expectations. Advertisement The company reported a fourth-quarter loss of $3.9 million, or 9 cents a share, compared with $5.4 million, or 13 cents in the year-ago quarter. Adjusted for certain one-time items, Axogen reported a los of 6 cents a share compared with 3 cents a share in the year-ago quarter. Analysts expected an adjusted loss of 7 cents a share. Fourth-quarter revenue increased 18.7% to $42.9 million year over year. Ana
Show less
Read more
Impact Snapshot
Event Time:
AXGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXGN alerts
High impacting Axogen, Inc. news events
Weekly update
A roundup of the hottest topics
AXGN
News
- Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™ [Yahoo! Finance]Yahoo! Finance
- Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™GlobeNewswire
- Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024GlobeNewswire
- Analysts Expect Breakeven For AxoGen, Inc. (NASDAQ:AXGN) Before Long [Yahoo! Finance]Yahoo! Finance
- Director Gregory Freitag Sells 25,000 Shares of Axogen Inc (AXGN) [Yahoo! Finance]Yahoo! Finance
AXGN
Earnings
- 3/5/24 - Beat
AXGN
Sec Filings
- 4/30/24 - Form EFFECT
- 4/24/24 - Form DEF
- 4/24/24 - Form ARS
- AXGN's page on the SEC website